Anagenics Ltd

AU:AN1 Australia Household & Personal Products
Market Cap
$3.66 Million
AU$5.91 Million AUD
Market Cap Rank
#36715 Global
#1408 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.70
Categories
Companies in Australia Household & Personal Products
About

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pac… Read more

Anagenics Ltd (AN1) - Net Assets

Latest net assets as of December 2025: AU$2.27 Million AUD

Based on the latest financial reports, Anagenics Ltd (AN1) has net assets worth AU$2.27 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.10 Million) and total liabilities (AU$1.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$2.27 Million
% of Total Assets 55.48%
Annual Growth Rate -5.72%
5-Year Change -82.5%
10-Year Change -61.06%
Growth Volatility 94.37

Anagenics Ltd - Net Assets Trend (2006–2025)

This chart illustrates how Anagenics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Anagenics Ltd (2006–2025)

The table below shows the annual net assets of Anagenics Ltd from 2006 to 2025.

Year Net Assets Change
2025-06-30 AU$1.83 Million -32.60%
2024-06-30 AU$2.71 Million -69.54%
2023-06-30 AU$8.90 Million +7.31%
2022-06-30 AU$8.29 Million -20.55%
2021-06-30 AU$10.43 Million +6.36%
2020-06-30 AU$9.81 Million +67.50%
2019-06-30 AU$5.86 Million +215.73%
2018-06-30 AU$1.86 Million -57.79%
2017-06-30 AU$4.40 Million -6.29%
2016-06-30 AU$4.69 Million +24.28%
2015-06-30 AU$3.77 Million -33.37%
2014-06-30 AU$5.66 Million +6.76%
2013-06-30 AU$5.31 Million +153.90%
2012-06-30 AU$2.09 Million +2.53%
2011-06-30 AU$2.04 Million -28.47%
2010-06-30 AU$2.85 Million +285.70%
2009-06-30 AU$738.65K +19.98%
2008-06-30 AU$615.63K -59.84%
2007-06-30 AU$1.53 Million -72.57%
2006-06-30 AU$5.59 Million --

Equity Component Analysis

This analysis shows how different components contribute to Anagenics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 6101404500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$67.18 Million 3678.16%
Other Comprehensive Income AU$-57.27K -3.14%
Total Equity AU$1.83 Million 100.00%

Anagenics Ltd Competitors by Market Cap

The table below lists competitors of Anagenics Ltd ranked by their market capitalization.

Company Market Cap
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
 		$738.54K
Kedaung Indah Can Tbk
JK:KICI
 		$739.07K
2U, Inc.
PINK:TWOUQ
 		$739.61K
Yubo International Biotech Limited
PINK:YBGJ
 		$740.35K
Thai Textile Industry Public Company Limited
BK:TTI
 		$737.97K
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO
 		$737.52K
Lehto Group Oyj
F:L7G
 		$737.47K
Goldflare Exploration Inc
V:GOFL
 		$737.13K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Anagenics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,709,854 to 1,826,488, a change of -883,366 (-32.6%).
  • Net loss of 1,235,675 reduced equity.
  • Other comprehensive income increased equity by 2,308.
  • Other factors increased equity by 350,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-1.24 Million -67.65%
Other Comprehensive Income AU$2.31K +0.13%
Other Changes AU$350.00K +19.16%
Total Change AU$- -32.60%

Book Value vs Market Value Analysis

This analysis compares Anagenics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.54x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.00x to 1.54x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-06-30 AU$2.97 AU$0.01 x
2007-06-30 AU$0.51 AU$0.01 x
2008-06-30 AU$0.17 AU$0.01 x
2009-06-30 AU$0.11 AU$0.01 x
2010-06-30 AU$0.19 AU$0.01 x
2011-06-30 AU$0.11 AU$0.01 x
2012-06-30 AU$0.09 AU$0.01 x
2013-06-30 AU$0.17 AU$0.01 x
2014-06-30 AU$0.15 AU$0.01 x
2015-06-30 AU$0.09 AU$0.01 x
2016-06-30 AU$0.10 AU$0.01 x
2017-06-30 AU$0.08 AU$0.01 x
2018-06-30 AU$0.03 AU$0.01 x
2019-06-30 AU$0.07 AU$0.01 x
2020-06-30 AU$0.09 AU$0.01 x
2021-06-30 AU$0.07 AU$0.01 x
2022-06-30 AU$0.04 AU$0.01 x
2023-06-30 AU$0.03 AU$0.01 x
2024-06-30 AU$0.01 AU$0.01 x
2025-06-30 AU$0.00 AU$0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Anagenics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -67.65%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -26.04%
  • • Asset Turnover: 1.16x
  • • Equity Multiplier: 2.25x
  • Recent ROE (-67.65%) is above the historical average (-130.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 -50.06% 0.00% 0.00x 1.11x AU$-3.31 Million
2007 -297.12% 0.00% 0.00x 3.08x AU$-4.71 Million
2008 -436.76% 0.00% 0.00x 4.23x AU$-2.75 Million
2009 -451.44% 0.00% 0.00x 1.65x AU$-3.41 Million
2010 -47.03% 0.00% 0.00x 1.13x AU$-1.62 Million
2011 -111.37% -7224.00% 0.01x 1.38x AU$-2.47 Million
2012 -93.63% -1395.45% 0.06x 1.20x AU$-2.18 Million
2013 -28.65% -281.90% 0.09x 1.12x AU$-2.06 Million
2014 -26.02% -67.09% 0.34x 1.14x AU$-2.04 Million
2015 -88.43% -181.10% 0.30x 1.63x AU$-3.71 Million
2016 -74.60% -112.13% 0.42x 1.58x AU$-3.97 Million
2017 -101.71% -99.42% 0.53x 1.93x AU$-4.91 Million
2018 -201.20% -66.09% 0.84x 3.64x AU$-3.92 Million
2019 -100.89% -80.93% 0.75x 1.67x AU$-6.50 Million
2020 -50.02% -66.49% 0.50x 1.52x AU$-5.89 Million
2021 -32.46% -58.23% 0.44x 1.27x AU$-4.43 Million
2022 -44.02% -52.54% 0.54x 1.56x AU$-4.48 Million
2023 -29.98% -29.27% 0.82x 1.25x AU$-3.56 Million
2024 -276.52% -69.36% 1.74x 2.29x AU$-7.76 Million
2025 -67.65% -26.04% 1.16x 2.25x AU$-1.42 Million

Industry Comparison

This section compares Anagenics Ltd's net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

  • Industry: Household & Personal Products
  • Average net assets among peers: $63,354,352
  • Average return on equity (ROE) among peers: -4.44%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Anagenics Ltd (AN1) AU$2.27 Million -50.06% 0.80x $738.39K
Mcphersons Ltd (MCP) $141.09 Million 0.66% 1.64x $12.59 Million
Prestal Holdings Ltd (PTL) $83.13 Million 11.63% 0.70x $1.14 Million
Star Combo Pharma Ltd (S66) $20.00 Million -8.63% 0.38x $1.46 Million
Skin Elements Ltd (SKN) $9.20 Million -21.40% 0.08x $4.15 Million